dc.creatorHugenholtz, Jeroen
dc.creatorSybesma, Wilbert
dc.creatorGroot, Masja Nierop
dc.creatorWisselink, Wouter
dc.creatorLadero, Victor
dc.creatorBurgess, Kay
dc.creatorvan Sinderen, Douwe
dc.creatorPiard, Jean-Christophe
dc.creatorEggink, Gerrit
dc.creatorSmid, Eddy J.
dc.creatorSavoy, Graciela
dc.creatorSesma, Fernando Juan Manuel
dc.creatorJansen, Tanja
dc.creatorHols, Pascal
dc.creatorKleerebezem, Michiel
dc.date.accessioned2018-09-06T22:03:40Z
dc.date.accessioned2018-11-06T12:44:55Z
dc.date.available2018-09-06T22:03:40Z
dc.date.available2018-11-06T12:44:55Z
dc.date.created2018-09-06T22:03:40Z
dc.date.issued2002-08
dc.identifierHugenholtz, Jeroen; Sybesma, Wilbert; Groot, Masja Nierop; Wisselink, Wouter; Ladero, Victor; et al.; Metabolic engineering of lactic acid bacteria for the production of nutraceuticals; Springer; Antonie van Leeuwenhoek; 82; 1-4; 8-2002; 217-235
dc.identifier0003-6072
dc.identifierhttp://hdl.handle.net/11336/58654
dc.identifier1572-9699
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1869752
dc.description.abstractLactic acid bacteria display a relatively simple and well-described metabolism where the sugar source is converted mainly to lactic acid. Here we will shortly describe metabolic engineering strategies on the level of sugar metabolism, that lead to either the efficient re-routing of the lactococcal sugar metabolism to nutritional end-products other than lactic acid such as L-alanine, several low-calorie sugars and oligosaccharides or to enhancement of sugar metabolism for complete removal of (undesirable) sugars from food materials. Moreover, we will review current metabolic engineering approaches that aim at increasing the flux through complex biosynthetic pathways, leading to the production of the B-vitamins folate and riboflavin. An overview of these metabolic engineering activities can be found on the website of the Nutra Cells 5th Framework EU-project (www.nutracells.com). Finally, the impact of the developments in the area of genomics and corresponding high-throughput technologies on nutraceutical production will be discussed.
dc.languageeng
dc.publisherSpringer
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1023%2FA%3A1020608304886
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1023%2FA%3A1020608304886
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectLACTIC ACID BACTERIA
dc.subjectNUTRACEUTICALS
dc.subjectFUNCTIONAL FOODS
dc.subjectFOLATE
dc.subjectGALACTOSE
dc.subjectLACTOCOCCUS LACTIS
dc.subjectLOW-CALORIE SUGARS
dc.subjectMANNITOL
dc.subjectMETABOLIC ENGINEERING
dc.subjectOLIGOSACCHARIDES
dc.subjectRIBOFLAVIN
dc.subjectSORBITOL
dc.subjectTAGATOSE
dc.titleMetabolic engineering of lactic acid bacteria for the production of nutraceuticals
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución